Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 12-2008 | 06-2008 | 12-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,963 | 586 | 557 | 774 | 1,020 |
| Marketable Securities | 1,977 | 2,440 | 3,445 | 4,359 | 4,998 |
| Inventories | 123 | 131 | 103 | 90 | 96 |
| Other current assets | 356 | 266 | 341 | 300 | 267 |
| TOTAL | $8,458 | $3,423 | $4,541 | $5,523 | $6,481 |
| Non-Current Assets | |||||
| PPE Net | 81 | 98 | 122 | 131 | 146 |
| Intangibles | 127 | 134 | 109 | 107 | 99 |
| TOTAL | $208 | $232 | $231 | $238 | $245 |
| Total Assets | $8,666 | $3,655 | $4,772 | $5,761 | $6,726 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3 | N/A | 2 | N/A | 2 |
| Accounts payable and accrued liabilities | 134 | 538 | 240 | 555 | 110 |
| TOTAL | $665 | $541 | $580 | $557 | $464 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2 | 0 | 5 | 0 | 8 |
| TOTAL | $2 | $3 | $5 | $6 | $8 |
| Total Liabilities | $667 | $544 | $585 | $563 | $472 |
| Shareholders' Equity | |||||
| Common Shares | 597 | 224 | 217 | 217 | 217 |
| Retained earnings | -7,806 | -6,499 | -5,416 | -4,405 | -3,349 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $7,999 | $3,111 | $4,187 | $5,198 | $6,254 |
| Total Liabilities And Equity | $8,666 | $3,655 | $4,772 | $5,761 | $6,726 |